Citizens Business Bank Gilead Sciences, Inc. Transaction History

Citizens Business Bank

  • $476 Million
  • Q3 2024

A detailed history of Citizens Business Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Citizens Business Bank holds 6,853 shares of GILD stock, worth $629,653. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,853
Previous 6,853 -0.0%
Holding current value
$629,653
Previous $470,000 22.13%
% of portfolio
0.12%
Previous 0.1%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 19, 2024
SELL
$66.59 - $83.99 $13,717 - $17,301
-206 Reduced 3.01%
6,647 $557,000
Q2 2024

Aug 02, 2024
BUY
$63.15 - $72.88 $100,155 - $115,587
1,586 Added 30.11%
6,853 $470,000
Q1 2024

Apr 17, 2024
BUY
$71.58 - $87.29 $3,221 - $3,928
45 Added 0.86%
5,267 $385,000
Q4 2023

Feb 05, 2024
BUY
$73.27 - $83.09 $22,054 - $25,010
301 Added 6.12%
5,222 $423,000
Q3 2023

Nov 02, 2023
SELL
$73.94 - $80.67 $19,002 - $20,732
-257 Reduced 4.96%
4,921 $368,000
Q2 2023

Aug 07, 2023
BUY
$76.01 - $86.7 $393,579 - $448,932
5,178 New
5,178 $399,000
Q2 2022

Nov 18, 2022
SELL
$57.72 - $65.01 $346 - $390
-6 Reduced 0.02%
24,905 $1.54 Million
Q1 2022

Nov 18, 2022
BUY
$57.92 - $72.58 $714,559 - $895,419
12,337 Added 98.12%
24,911 $1.48 Million
Q4 2021

Nov 18, 2022
SELL
$64.88 - $73.64 $7,266 - $8,247
-112 Reduced 0.88%
12,574 $913,000
Q3 2021

Nov 18, 2022
BUY
$67.69 - $73.03 $217,284 - $234,426
3,210 Added 33.88%
12,686 $886,000
Q2 2021

Nov 18, 2022
BUY
$63.47 - $69.35 $163,498 - $178,645
2,576 Added 37.33%
9,476 $653,000
Q4 2019

Nov 18, 2022
SELL
$61.62 - $67.78 $727,116 - $799,804
-11,800 Reduced 63.1%
6,900 $448,000
Q1 2019

Nov 18, 2022
SELL
$62.53 - $70.05 $31,265 - $35,025
-500 Reduced 2.6%
18,700 $1.22 Million
Q4 2018

Nov 18, 2022
SELL
$60.54 - $79.0 $1.25 Million - $1.64 Million
-20,700 Reduced 51.88%
19,200 $1.2 Million
Q3 2018

Nov 18, 2022
SELL
$71.28 - $78.92 $384,912 - $426,168
-5,400 Reduced 11.92%
39,900 $3.08 Million
Q2 2018

Nov 18, 2022
BUY
$64.88 - $75.68 $395,768 - $461,648
6,100 Added 15.56%
45,300 $3.21 Million
Q1 2018

Nov 18, 2022
SELL
$72.84 - $88.8 $200,310 - $244,200
-2,750 Reduced 6.56%
39,200 $2.96 Million
Q4 2017

Nov 18, 2022
BUY
$71.15 - $83.52 $421,777 - $495,106
5,928 Added 16.46%
41,950 $3.01 Million
Q3 2017

Nov 18, 2022
BUY
$72.11 - $85.47 $407,782 - $483,332
5,655 Added 18.62%
36,022 $2.92 Million
Q2 2017

Nov 18, 2022
BUY
N/A
30,367 New
30,367 $2.15 Million
Q1 2017

Nov 18, 2022
BUY
N/A
13,358 Added 52.56%
38,773 $2.63 Million
Q4 2016

Nov 18, 2022
SELL
N/A
-1,675 Reduced 6.18%
25,415 $1.82 Million
Q3 2016

Nov 18, 2022
SELL
N/A
-1,780 Reduced 6.17%
27,090 $2.14 Million
Q2 2016

Nov 18, 2022
SELL
N/A
-781 Reduced 2.63%
28,870 $2.41 Million
Q1 2016

Nov 18, 2022
SELL
N/A
-2,131 Reduced 6.71%
29,651 $2.72 Million
Q4 2015

Nov 18, 2022
SELL
N/A
-2,503 Reduced 7.3%
31,782 $3.22 Million
Q3 2015

Nov 18, 2022
SELL
N/A
-1,175 Reduced 3.31%
34,285 $3.37 Million
Q2 2015

Nov 18, 2022
SELL
N/A
-1,474 Reduced 3.99%
35,460 $4.15 Million
Q1 2015

Nov 18, 2022
BUY
N/A
1,113 Added 3.11%
36,934 $3.63 Million
Q4 2014

Nov 18, 2022
SELL
N/A
-8,915 Reduced 19.93%
35,821 $3.38 Million
Q3 2014

Nov 18, 2022
BUY
N/A
630 Added 1.43%
44,736 $4.76 Million
Q2 2014

Nov 18, 2022
SELL
N/A
-659 Reduced 1.47%
44,106 $3.66 Million
Q1 2014

Nov 18, 2022
BUY
N/A
26,623 Added 146.75%
44,765 $3.17 Million
Q4 2013

Nov 18, 2022
BUY
N/A
5,123 Added 39.35%
18,142 $1.36 Million
Q3 2013

Nov 18, 2022
BUY
N/A
7,781 Added 148.55%
13,019 $819,000
Q2 2013

Nov 18, 2022
BUY
N/A
5,238
5,238 $269,000

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email